Components of the metabolic syndrome and colorectal cancer risk; a prospective study - PubMed (original) (raw)
Components of the metabolic syndrome and colorectal cancer risk; a prospective study
T Stocks et al. Int J Obes (Lond). 2008 Feb.
Abstract
Objective: To examine the relation of well-known factors of the metabolic syndrome (MetS) as well as related circulating factors, with risk of colorectal cancer.
Methods: We performed a case control study of 306 colorectal cancer cases and 595 matched controls nested in the Northern Sweden Health and Disease Cohort. Levels of C-peptide, glycated haemoglobin (HbA1c), leptin and adiponectin were measured in cryopreserved samples. Body mass index (BMI), systolic and diastolic blood pressure and fasting and post-load plasma glucose, had been measured in a subcohort. Conditional logistic regression was used to calculate odds ratios (OR) of disease, including risk assessments for the MetS factors: obesity (BMI>30 kg m(-2)), hypertension (blood pressure > or =140/90 mmHg or use of anti-hypertensive drugs) and hyperglycaemia (fasting glucose > or =6.1 mmol l(-1) or post-load glucose in capillary plasma > or =8.9 mmol l(-1)).
Results: None of the studied variables were significantly associated with risk across quartiles. Presence of obesity, hypertension and hyperglycaemia significantly increased the risk of colorectal cancer; OR for three vs null factors was 2.57 (95% Confidence Interval [CI] 1.20-5.52; P (trend)=0.0021), as compared to a 30 to 70% increased risk for the factors in single. Similarly, top decile levels of C-peptide, HbA1c and leptin/adiponectin ratio were associated with an increased risk; ORs for top vs deciles 1-9 were 1.56 (95% CI 0.93-2.62; P=0.090), 1.83 (95% CI 1.00-3.36; P=0.051) and 1.50 (95% CI 0.83-2.71; P=0.18), respectively.
Conclusions: Our study support the view that components of the MetS increase risk of colorectal cancer, and further suggests that only very high levels of metabolic factors confer an increased risk.
Similar articles
- Insulin resistance is inversely related to prostate cancer: a prospective study in Northern Sweden.
Stocks T, Lukanova A, Rinaldi S, Biessy C, Dossus L, Lindahl B, Hallmans G, Kaaks R, Stattin P. Stocks T, et al. Int J Cancer. 2007 Jun 15;120(12):2678-86. doi: 10.1002/ijc.22587. Int J Cancer. 2007. PMID: 17278097 - Ramadan Intermittent Fasting Affects Adipokines and Leptin/Adiponectin Ratio in Type 2 Diabetes Mellitus and Their First-Degree Relatives.
Abdullah K, Al-Habori M, Al-Eryani E. Abdullah K, et al. Biomed Res Int. 2020 Jul 28;2020:1281792. doi: 10.1155/2020/1281792. eCollection 2020. Biomed Res Int. 2020. PMID: 32775407 Free PMC article. - Associations of the metabolic syndrome and its components with cognitive impairment in older adults.
Feinkohl I, Janke J, Hadzidiakos D, Slooter A, Winterer G, Spies C, Pischon T. Feinkohl I, et al. BMC Geriatr. 2019 Mar 7;19(1):77. doi: 10.1186/s12877-019-1073-7. BMC Geriatr. 2019. PMID: 30845934 Free PMC article. - Association between markers of glucose metabolism and risk of colorectal cancer.
Xu J, Ye Y, Wu H, Duerksen-Hughes P, Zhang H, Li P, Huang J, Yang J, Wu Y, Xia D. Xu J, et al. BMJ Open. 2016 Jun 27;6(6):e011430. doi: 10.1136/bmjopen-2016-011430. BMJ Open. 2016. PMID: 27354075 Free PMC article. Review. - Association between obesity-related adipokines and colorectal cancer: a case-control study and meta-analysis.
Joshi RK, Kim WJ, Lee SA. Joshi RK, et al. World J Gastroenterol. 2014 Jun 28;20(24):7941-9. doi: 10.3748/wjg.v20.i24.7941. World J Gastroenterol. 2014. PMID: 24976730 Free PMC article. Review.
Cited by
- Exploring the association between metabolic syndrome, its components and subsequent cancer incidence: A cohort study in Catalonia.
López-Jiménez T, Plana-Ripoll O, Duarte-Salles T, Recalde M, Bennett M, Xavier-Cos F, Puente D. López-Jiménez T, et al. Cancer Med. 2024 Aug;13(16):e7400. doi: 10.1002/cam4.7400. Cancer Med. 2024. PMID: 39149842 Free PMC article. - Inflammation and cancer: friend or foe?
Turizo-Smith AD, Córdoba-Hernandez S, Mejía-Guarnizo LV, Monroy-Camacho PS, Rodríguez-García JA. Turizo-Smith AD, et al. Front Pharmacol. 2024 May 10;15:1385479. doi: 10.3389/fphar.2024.1385479. eCollection 2024. Front Pharmacol. 2024. PMID: 38799159 Free PMC article. Review. - Metabolic syndrome and risk of colorectal cancer: A Mendelian randomization study.
Chen Y, Kong W, Liu M, Li Q, Wang Y, Zheng Y, Zhou Y. Chen Y, et al. Heliyon. 2023 Dec 19;10(1):e23872. doi: 10.1016/j.heliyon.2023.e23872. eCollection 2024 Jan 15. Heliyon. 2023. PMID: 38223733 Free PMC article. - Association of Measures of Glucose Metabolism with Colorectal Cancer Risk in Older Chinese: A 13-Year Follow-up of the Guangzhou Biobank Cohort Study-Cardiovascular Disease Substudy and Meta-Analysis.
Wang SY, Zhang WS, Jiang CQ, Jin YL, Zhu T, Zhu F, Xu L. Wang SY, et al. Diabetes Metab J. 2024 Jan;48(1):134-145. doi: 10.4093/dmj.2022.0383. Epub 2024 Jan 3. Diabetes Metab J. 2024. PMID: 38173369 Free PMC article. - Systemic adiponectin levels in colorectal cancer and adenoma: a systematic review and meta-analysis.
Macleod A, Scheurlen KM, Burton JF, Parks MA, Sumy MSA, Gaskins JT, Galandiuk S. Macleod A, et al. Int J Obes (Lond). 2023 Oct;47(10):911-921. doi: 10.1038/s41366-023-01358-6. Epub 2023 Aug 25. Int J Obes (Lond). 2023. PMID: 37626126 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical